First-line hypomethylating agents for patients with high risk chronic myelomonocytic leukaemia

Publication date: February 2021Source: The Lancet Haematology, Volume 8, Issue 2Author(s): Nelli Bejanyan, Claudio Anasetti
Source: The Lancet Haematology - Category: Hematology Source Type: research